Skip to main content

Michael Weber, 27

Occupation

Certified general accountant

Story continues below advertisement

The portfolio

Includes shares in Bank of Nova Scotia, Enbridge Inc., Fortis Inc., Intel Corp., Johnson & Johnson, Medtronic Inc., SNC Lavalin Group Inc., Suncor Energy Inc., Telus Corp. and TransCanada Corp.

The investor

Michael Weber is saving a large portion of his salary and investing in stocks with growing dividends. He has crunched the numbers and estimates he can build up enough dividend income to become financially independent by his late 40s.

How he invests

Mr. Weber screens for stocks that have had their dividends raised for at least five consecutive years. The companies making the grade are subjected to a thorough analysis. They are purchased if they meet several selection criteria, including:

  • The company is able to grow per-share earnings at 8 per cent or more a year (thus capable of increasing the dividend by at least 8 per cent a year);
  • No more than 60 per cent of company earnings required to finance the dividend;
  • A sustainable competitive advantage as indicated by the return on equity being consistently above 12 per cent (or the industry average).

Dividend investors are sometimes accused of looking just at dividends. For Mr. Weber, it's also important to buy dividend stocks at good prices. He uses valuation yardsticks (price-to-earnings, price-to-book, etc.) to conservatively estimate a fair price – and waits patiently for it to come around. "I'm usually waiting for a few months before I buy something," Mr. Weber discloses.

Story continues below advertisement

Recent purchases

"I bought Suncor Energy on June 10 after its recent large dividend increase. Large increases like this are a sign from management that they expect good things in the future."

"I bought Intel in February, 2013. At the time, the price was discounted because of worries that they would be unable to enter the mobile industry successfully."

Best move

"My best investment so far has come from Medtronic. I bought it at $31 and it is about 70 per cent higher."

Worst move

Story continues below advertisement

"I bought [Research In Motion] at $28.67 [now trading around $10]. I still keep [the shares] in my account as a reminder not to stray from my investing strategy."

Advice

Mr. Weber provides plenty of advice on his blog, Dividend Growth Investing & Retirement.

Want to share your strategies?

E-mail mccolumn@yahoo.com

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies